Unintentional Role Models: Links Between Maternal Eating Psychopathology and the Modelling of Eating Behaviours.

Unintentional Role Models: Links Between Maternal Eating Psychopathology and the Modelling of Eating Behaviours.

Filed under: Depression Treatment

Eur Eat Disord Rev. 2013 Jan 25;
Palfreyman Z, Haycraft E, Meyer C

This study explored the relationships between maternal modelling of eating behaviours with reported symptoms of maternal eating psychopathology, anxiety and depression. Mothers (N?=?264) with a child aged 1.5 to 8?years completed three self-report measures designed to assess modelling of eating behaviours, eating psychopathology and levels of anxiety and depression. The study found that higher levels of maternal eating psychopathology were positively associated with eating behaviours that were unintentionally modelled by mothers but that maternal eating psychopathology was not associated with more overt/intentional forms of parental modelling. In addition, higher levels of maternal depression were associated with lower levels of both unintentional and intentional forms of maternal modelling, whereas maternal anxiety was not found to correlate with modelling behaviours. This study highlights the possible detrimental influences of maternal mental health in relation to mothers providing their child with a positive parental role model around eating and feeding. Copyright © 2013 John Wiley & Sons, Ltd and Eating Disorders Association.
HubMed – depression

Screening for depression: only one piece of the puzzle.

Filed under: Depression Treatment

Nephrol Dial Transplant. 2013 Jan 24;
Novak M, Mucsi I, Mendelssohn DC

In this issue of NDT, van den Beukel et al. from the Netherlands suggest that a 5-item survey questionnaire might be used to replace the Beck Depression Index to screen patients with chronic kidney disease (CKD) for depression. The nephrology community is at a tipping point in terms of the assessment of outcomes, especially among patients on dialysis. Indeed, the entire healthcare community has begun to shift its focus to patient-reported outcomes (PROs), including quality of life, patient satisfaction and the psychosocial determinants of health. Beyond depression, there are a myriad of aspects of psychological distress that include anxiety, worrying, fear of progression of kidney disease and the fear of the future in general, death and dying, hopelessness, questions around the meaning of life and the experience of recurrent psychological and physical trauma through the CKD trajectory. We encourage the community and its researchers to embrace and research PROs, with the aim to create a holistic, patient-centered model of care for patients at all stages of CKD, including those on chronic dialysis and after transplantation, keeping the whole person-and their families-in mind.
HubMed – depression

Comorbid Conditions and Outcomes in Patients With Pulmonary Arterial Hypertension: A REVEAL Registry Analysis.

Filed under: Depression Treatment

Chest. 2013 Jan 24;
Poms AM, Turner M, Farber HW, Meltzer LA, McGoon MD

ABSTRACT BACKGROUND: Comorbidities can affect disease progression and/or response to treatment in various conditions. Comorbid conditions are prevalent in patients with pulmonary arterial hypertension (PAH); however, their effect on patient outcomes remains unknown. METHODS: We evaluated the effect on functional class (FC), 6-minute walk test distance (6MWD), and survival of the 7 most common comorbid conditions at enrollment in patients with PAH from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL): hypertension, clinical depression, type II diabetes mellitus (diabetes), obesity, chronic obstructive pulmonary disease (COPD), sleep apnea, and thyroid disease. RESULTS: Patients with COPD or diabetes had the shortest 6MWD at enrollment (304.5 and 304.6 m, respectively) versus other comorbidities. Adjusted linear regression for 6MWD at enrollment revealed significant reductions among hypertensive, obese, diabetic, and COPD patients (P<.001). A larger proportion of obese or COPD patients were FC III/IV versus FC I/II at enrollment (P<.001). There was a greater risk of death among patients with diabetes (hazard ratio [HR], 1.73; 95% CI, 1.40-2.13; P<.001) or COPD (HR, 1.59; 95% CI, 1.34-1.90; P<.001) but a reduced risk in obese patients (HR, 0.73; 95% CI, 0.61-0.86; P<.001). CONCLUSIONS: Compared with other analyzed comorbidities in PAH patients, hypertension, obesity, diabetes, and COPD were associated with significantly worse 6MWD; obesity and COPD with worse FC; and diabetes and COPD with increased risk of death. Further investigation of the effects of treating these comorbidities in patients with PAH is warranted. CLINICALTRIALS.GOV IDENTIFIER: NCT00370214.
HubMed – depression

NEW Understanding Teenage Depression: A Guide to Diagnosis, Treatment, and Manag

$16.85 End Date: Tuesday Oct-25-2016 17:46:36 PDT Buy It Now for only: $16.85 Buy It Now | Add to watch list

$6.99 End Date: Saturday Nov-5-2016 16:49:41 PDT Buy It Now for only: $6.99 Buy It Now | Add to watch list

$1.80 End Date: Wednesday Oct-19-2016 10:19:57 PDT Buy It Now for only: $1.80 Buy It Now | Add to watch list

More Depression Treatment Information…